StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Interpace Biosciences's operating margin for the twelve months ending Jun 30, 2026 was 11.5%. For fiscal 2025 it was 10.5%, against 17.3% the year before. The highest annual figure on record is 17.3% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202510.5%−6.7
FY2024Dec 31, 202417.3%+7.4
FY2023Dec 31, 20239.9%+21.2
FY2022Dec 31, 2022-11.4%+65.9
FY2021Dec 31, 2021-77.3%+3.2
FY2020Dec 31, 2020-80.5%+28.7
FY2019Dec 31, 2019-109.1%−51.5
FY2018Dec 31, 2018-57.7%−18.1
FY2017Dec 31, 2017-39.6%+9.6
FY2016Dec 31, 2016-49.2%+379.2
FY2015Dec 31, 2015-428.4%+780.9
FY2014Dec 31, 2014-1209.4%−1208.4
FY2013Dec 31, 2013-1.0%+18.9
FY2012Dec 31, 2012-19.9%−16.9
FY2011Dec 31, 2011-3.0%+2.1
FY2010Dec 31, 2010-5.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20263.5%+8.6
Q1 FY2026Mar 31, 202612.4%−3.5
Q4 FY2025Dec 31, 202517.1%+0.5
Q3 FY2025Sep 30, 202513.1%−5.6
Q2 FY2025Jun 30, 2025-5.1%−26.9
Q1 FY2025Mar 31, 202515.9%+4.9
Q4 FY2024Dec 31, 202416.6%+1.9
Q3 FY2024Sep 30, 202418.7%+14.2
Q2 FY2024Jun 30, 202421.9%+10.8
Q1 FY2024Mar 31, 202410.9%+2.3
Q4 FY2023Dec 31, 202314.7%+14.5
Q3 FY2023Sep 30, 20234.5%+66.0
Q2 FY2023Jun 30, 202311.0%+108.9
Q1 FY2023Mar 31, 20238.7%+48.5
Q4 FY2022Dec 31, 20220.2%+8.0
Q3 FY2022Sep 30, 2022-61.6%−38.9
Q2 FY2022Jun 30, 2022-97.9%−71.8
Q1 FY2022Mar 31, 2022-39.8%−1.0
Q4 FY2021Dec 31, 2021-7.8%+74.5
Q3 FY2021Sep 30, 2021-22.7%+50.2
Q2 FY2021Jun 30, 2021-26.1%+79.9
Q1 FY2021Mar 31, 2021-38.8%+31.3
Q4 FY2020Dec 31, 2020-82.3%+173.3
Q3 FY2020Sep 30, 2020-72.8%+19.5
Q2 FY2020Jun 30, 2020-106.0%−20.7
Q1 FY2020Mar 31, 2020-70.1%−17.2
Q4 FY2019Dec 31, 2019-255.6%−169.5
Q3 FY2019Sep 30, 2019-92.3%−49.5
Q2 FY2019Jun 30, 2019-85.3%−50.8
Q1 FY2019Mar 31, 2019-53.0%+14.6
Q4 FY2018Dec 31, 2018-86.1%−10.6
Q3 FY2018Sep 30, 2018-42.8%+30.8
Q2 FY2018Jun 30, 2018-34.5%+58.8
Q1 FY2018Mar 31, 2018-67.5%−174.1
Q4 FY2017Dec 31, 2017-75.5%−291.3
Q3 FY2017Sep 30, 2017-73.7%+122.0
Q2 FY2017Jun 30, 2017-93.3%–
Q1 FY2017Mar 31, 2017106.6%–
Q4 FY2016Dec 31, 2016215.9%–
Q3 FY2016Sep 30, 2016-195.7%–

More Interpace Biosciences figures

See a number that looks wrong?